China Medicine Corporation
Symboli: CHME
PNK
0.028
USDMarkkinahinta tänään
0.0009
P/E-suhde
-0.0001
PEG-suhde
79.67M
MRK Cap
- 0.00%
DIV Tuotto
China Medicine Corporation (CHME) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.5 | 2.8 | 5.8 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 22.3 | 19.8 | 13.6 | ||||||
balance-sheet.row.inventory | 0 | 2.7 | 4.7 | 3.9 | ||||||
balance-sheet.row.other-current-assets | 0 | 0.5 | 6.3 | 6.1 | ||||||
balance-sheet.row.total-current-assets | 0 | 30.3 | 33.7 | 29.4 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12 | 3.8 | 1.4 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.long-term-investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 6 | 0.7 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 36.6 | 11 | 3.2 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.1 | 0 | ||||||
balance-sheet.row.short-term-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0.8 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 1 | 0.9 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.9 | 0 | 0 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-liab | 0 | 21.3 | 1.1 | 0.9 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 0 | 22.9 | 22.1 | 14 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 4.4 | 4.4 | 4.3 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 17.7 | 16.2 | 12.6 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 45 | 42.8 | 30.9 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.minority-interest | 0 | 0.5 | 0.8 | 0.9 | ||||||
balance-sheet.row.total-equity | 0 | 45.5 | 43.6 | 31.8 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.net-debt | 0 | 9 | -2.8 | -5.8 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1.4 | 9.1 | 6.9 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 0.1 | 0 | ||||||
cash-flows.row.change-in-working-capital | 0 | 7.1 | -5.4 | -10.1 | ||||||
cash-flows.row.account-receivables | 0 | -2.3 | -4.8 | 0 | ||||||
cash-flows.row.inventory | 0 | 3.4 | -0.5 | -1.8 | ||||||
cash-flows.row.account-payables | 0 | 0.6 | 0 | 0 | ||||||
cash-flows.row.other-working-capital | 0 | 5.4 | -0.1 | -8.2 | ||||||
cash-flows.row.other-non-cash-items | 0 | 7.3 | -0.1 | 0.1 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.acquisitions-net | 0 | -8 | 0 | 0 | ||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -5.2 | 0 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-investing-activites | 0 | -1.9 | 0 | 0 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.5 | -7.9 | -0.4 | ||||||
cash-flows.row.debt-repayment | 0 | -10.6 | 0 | 0 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7.8 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.4 | 0 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5.7 | 0.4 | 7.8 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.3 | 0.3 | ||||||
cash-flows.row.net-change-in-cash | 0 | -2.3 | -3 | 5.4 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.5 | 2.8 | 5.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.8 | 5.8 | 0.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | 17 | 4.2 | -2.3 | ||||||
cash-flows.row.capital-expenditure | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 13.3 | 1.5 | -2.7 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 64.8 | 53.6 | 42.1 | ||||||
income-statement-row.row.cost-of-revenue | 0 | 45.8 | 38.1 | 29.7 | ||||||
income-statement-row.row.gross-profit | 0 | 19 | 15.6 | 12.4 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.operating-expenses | 0 | 6.7 | 4.6 | 4 | ||||||
income-statement-row.row.cost-and-expenses | 0 | 52.5 | 42.7 | 33.7 | ||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.total-operating-expenses | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||
income-statement-row.row.operating-income | 0 | 12.3 | 10.9 | 8.4 | ||||||
income-statement-row.row.income-before-tax | 0 | 5 | 11 | 8.4 | ||||||
income-statement-row.row.income-tax-expense | 0 | 3.5 | 2 | 1.6 | ||||||
income-statement-row.row.net-income | 0 | 1.7 | 9.1 | 6.9 |
Usein kysytty kysymys
Mikä on China Medicine Corporation (CHME) taseen loppusumma?
China Medicine Corporation (CHME) kokonaisvarat ovat 66844482.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.293.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.870.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.027.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.189.
Mikä on China Medicine Corporation (CHME) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 1717677.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 9506160.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 6718099.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.